# Evaluation of the Feasibility, Safety, and Efficacy of Single-use Endobronchial Silicon Spigots for the Treatment of Refractory Pneumothorax

> **NCT06515015** · NA · RECRUITING · sponsor: **Hangzhou Broncus Medical Co., Ltd.** · enrollment: 10 (estimated)

## Conditions studied

- Pneumothorax

## Interventions

- **DEVICE:** Endobronchial Silicon Spigots

## Key facts

- **NCT ID:** NCT06515015
- **Lead sponsor:** Hangzhou Broncus Medical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06515015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06515015, "Evaluation of the Feasibility, Safety, and Efficacy of Single-use Endobronchial Silicon Spigots for the Treatment of Refractory Pneumothorax". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06515015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*